“We may have underestimated our ability to pivot and change rapidly,” Peter Merkel, M D, MPH, comments about the many ways Covid-19 has reshaped the way we conduct clinical trials ” and some of those changes could help democratize trials.
“We may have underestimated our ability to pivot and change rapidly,” Peter Merkel, M D, MPH, comments about the many ways Covid-19 has reshaped the way we conduct clinical trials ” and some of those changes could help democratize trials.